Clorox Company (The)

Valuation Analysis

About the Company

Clorox Company (The) en bref

Clorox Company (The) (CLX) is currently trading at 83,51 € with a market capitalization of 10,1 Md €. The trailing P/E ratio stands at 15.58x, with a forward P/E of 15.3x. The 52-week range spans from 73,84 € to 115,10 €; the current price is 27.4% below the yearly high. Year-over-year revenue growth stands at +0.1%. The net profit margin stands at 11.18%.

💰 Dividende

Clorox Company (The) pays an annual dividend of 4,32 € per share, representing a yield of 5.18%. The payout ratio stands at 80.33%. The elevated payout ratio reflects a mature dividend policy.

📊 Avis des analystes

17 analystes évaluent Clorox Company (The) (CLX) au consensus : Conserver. L'objectif de cours moyen est de 91,79 €, soit un potentiel de +9.91% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 72,36 € à 142,10 €.

Clorox Company (The) : la thèse d'investissement en détail

Clorox Company (The) (CLX) operates in the Consumer Defensive — specifically Household & Personal Products — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

The combination of a 43.85% gross margin and 17.01% operating margin shows the business converts revenue into profit efficiently — a hallmark of competitive moat. Return on equity of 546.1% places management among the most capital-efficient operators in the public market — every euro of shareholder capital is working hard. Our valuation screen flags the stock as undervalued relative to its fundamentals — multiples are running below where the cash flow profile would normally justify.

Le scénario baissier

Revenue growth has slowed to just 0.1%, which is below nominal GDP — the business is no longer outgrowing the broader economy. The debt-to-equity ratio of 4876.09% is elevated, meaning the company relies heavily on creditors — refinancing terms will become more important than operational performance in the next economic downturn.

À surveiller

• The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.

Thèse d'investissement : forces et faiblesses

Aperçu technique

The price is in a transition zone relative to the moving averages — no clear signal.

Profil de risque

The data points to relatively defensive market behavior, elevated short interest (8.85%), higher leverage relative to equity.

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Clorox Company (The)?

Compare top-rated brokers — low fees, trusted providers, fully regulated.